TrialJournal for immunotherapy of cancer2020

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial.

Javier Martin-Broto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.